Ratnoff O
J Exp Med. 2009; 122(5):905-21.
PMID: 19867295
PMC: 2138110.
DOI: 10.1084/jem.122.5.905.
Mason B, Sparrow E
Br J Pharmacol Chemother. 2008; 25(1):257-69.
PMID: 19108206
PMC: 1510693.
DOI: 10.1111/j.1476-5381.1965.tb01780.x.
Eisen V
J Physiol. 1963; 166(3):496-513.
PMID: 16992149
PMC: 1359349.
DOI: 10.1113/jphysiol.1963.sp007119.
Moses J, Ebert R, Graham R, BRINE K
J Exp Med. 1964; 120:57-82.
PMID: 14194393
PMC: 2137718.
DOI: 10.1084/jem.120.1.57.
Eisen V
Br J Pharmacol Chemother. 1964; 22:87-103.
PMID: 14126061
PMC: 1703902.
DOI: 10.1111/j.1476-5381.1964.tb01546.x.
[Recent results in the field of plasma kinins].
TRAUTSCHOLD I, RUDEL G
Klin Wochenschr. 1963; 41:297-311.
PMID: 13994008
DOI: 10.1007/BF01484325.
HLA typing in a new family with Fletcher factor deficiency.
Raffoux C, Alexandre P, Perrier P, Briquel M, Streiff F
Hum Genet. 1982; 60(1):71-3.
PMID: 6918357
DOI: 10.1007/BF00281268.
The release of a bradykinin-like pulmonary vasodilator substance in foetal and new-born lambs.
Campbell A, Dawes G, Fishman A, HYMAN A, PERKS A
J Physiol. 1968; 195(1):83-96.
PMID: 5639804
PMC: 1557904.
DOI: 10.1113/jphysiol.1968.sp008447.
The isolation of human plasma prekallikrein.
McConnell D, Mason B
Br J Pharmacol. 1970; 38(3):490-502.
PMID: 5445687
PMC: 1702563.
DOI: 10.1111/j.1476-5381.1970.tb10591.x.
[Venous admixture and lymphogranulomatosis (Hodgkin's disease)].
Kunkel G, HUTTEMANN U, Rufer R
Klin Wochenschr. 1969; 47(4):190-7.
PMID: 5369569
DOI: 10.1007/BF01725675.
Separation of plasma thromboplastin antecedent from kallikrein by the plasma 2 -macroglobulin, kallikrein inhibitor.
HARPEL P
J Clin Invest. 1971; 50(10):2084-90.
PMID: 5165598
PMC: 292142.
DOI: 10.1172/JCI106702.
On the paw edema induced by subcutaneous injection of minute glass particles in the rat.
RIESTERER L, MAJER H, Jaques R
Agents Actions. 1971; 2(1):27-32.
PMID: 5129521
DOI: 10.1007/BF01965377.
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. I. Isolation and purification of plasma kallikreins.
Colman R, Mattler L, Sherry S
J Clin Invest. 1969; 48(1):11-22.
PMID: 4974623
PMC: 322187.
DOI: 10.1172/JCI105959.
Kinin formation and kininogen depletion in rats after intravenous injection of ellagic acid.
Gautvik K, Rugstad H
Br J Pharmacol Chemother. 1967; 31(3):390-400.
PMID: 4966318
PMC: 1557345.
DOI: 10.1111/j.1476-5381.1967.tb00406.x.
Lowering of kininogen in rat blood by adrenaline and its inhibition by sympatholytic agents, heparin and aspirin.
Castania A, Rothschild A
Br J Pharmacol. 1974; 50(3):375-81.
PMID: 4853047
PMC: 1776676.
DOI: 10.1111/j.1476-5381.1974.tb09612.x.
[The influence of ellagic acid on the oncolytic effect of clostridium M55 (author's transl)].
Mose J, Fischer G
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol. 1974; 82(2):143-52.
PMID: 4370579
DOI: 10.1007/BF00284499.
Studies on the interaction between collagen and a plasma kallikrein-like activity. Evidence for a surface-active enzyme system.
HARPEL P
J Clin Invest. 1972; 51(7):1813-22.
PMID: 4338122
PMC: 292329.
DOI: 10.1172/jci106983.
Studies on the prekallikrein (kallikreinogen)--kallikrein enzyme system of human plasma. II. Evidence relating the kaolin-activated arginine esterase to plasma kallikrein.
Colman R, Mattler L, Sherry S
J Clin Invest. 1969; 48(1):23-32.
PMID: 4237065
PMC: 322188.
DOI: 10.1172/JCI105971.
Permeability factor and kininogenase in guinea-pig serum fractions.
Mason B
Br J Exp Pathol. 1972; 53(4):427-34.
PMID: 4115990
PMC: 2072407.
Human plasma alpha 2-macroglobulin. An inhibitor of plasma kallikrein.
HARPEL P
J Exp Med. 1970; 132(2):329-52.
PMID: 4101346
PMC: 2138741.
DOI: 10.1084/jem.132.2.329.